This Viewpoint discusses regulatory and public health challenges related to the availability of powdered alcohol products.
This Viewpoint describes research approaches to evaluating wellness interventions, such as hybrid study designs, large population cohorts and biobanks, and citizen scientists and social networks.
This Viewpoint discusses whether financially rewarding reductions in 10-year predicted risk for atherosclerotic heart disease across a physician’s patient population is an effective model for value-based prevention.
This study uses Framingham cohort data to assess whether the 2013 American College of Cardiology/American Heart Association guidelines for cholesterol management improve identification of adults at higher risk of cardiovascular events compared with the 2004 Adult Treatment Panel III guidelines.
This study compares the cost-effectiveness of using various 10-year atherosclerotic cardiovascular disease risk thresholds for initiating statin therapy.
This open-label randomized trial characterizes reductions in serum potassium levels and adverse events among patients with hyperkalemia and diabetes treated with patiromer, an oral potassium binder.
This study describes the clinical and genetic characteristics of pregnant women with maternal-fetal karyotype discordance on noninvasive prenatal testing attributable to subsequently diagnosed malignancy.
This review summarizes approaches to managing hypertension in octogenarians based on guidelines of international expert organizations.
This From The JAMA Network article discusses a recent JAMA Psychiatry report on a randomized clinical trial of dialectical behavior therapy for individuals with borderline personality disorder and high suicide risk.
This study reports on the changes to the vaccination recommendations by the US Centers for Disease Control and Prevention Advisory Committee on Immunization Practices and the status of implementation of requirements by the states.
This Medical News & Perspectives article describes a new guideline for physicians treating adults after a first seizure, emphasizing a patient-centered approach in the discussion of treatment options.